Category: Drug Discovery
North America Drug Discovery
-
Ophthalmic Drugs Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The global ophthalmic drugs market is experiencing substantial growth, and ... Read More
-
Oligonucleotide Synthesis Market,By Equipment and Services (Equipment/Synthesizer (Nucleic Acid Synthesizer, Peptide Synthesizer), Reagents, Services, (Oligo Synthesis, Modification, Purification)), By Technology (Column-based, Microarray-based), By Nucleic Acid (DNA, RNA), By Application (Drug Discovery, Therapeutics), By End User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical-biotechnology Companies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical-biotechnology Companies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Oligonucleotide therapeutics have revolutionized the pharmaceutical industry. They are a class of drugs and ... Read More
-
US Kidney Cancer Therapeutics and Diagnostics Market to 2028
... increase in success rate of targeted therapies, expansion of hospitals and NCI- funded cancer centers, and constant growth in population. Advancement in therapeutic approaches, including targeted therapies, immunotherapies, checkpoint inhibitors, and personalized medicines, have revolutionized ... Read More
-
North America Gene Expression Analysis Market By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microarrays, Others), By Product Type (Instruments, Reagents and Consumables, Services), By End-User (Drug Discovery & Development, Diagnostic Laboratories, Academic Research Centers), By Country, Competition, Forecast & Opportunities, 2018-2028
... Research Centers), By Country, Competition, Forecast & Opportunities, 2018-2028 North America Gene Expression Analysis Market is anticipated to project impressive growth in the forecast period. The North America Gene Expression Analysis Market is a dynamic ... Read More
-
United States Psychedelic Mushroom Market By Product Type (Psilocybe (Psilocybe cubensis, Psilocybe semilanceata, Psilocybe azurescens, Psilocybe cyanescens, Psilocybe baeocystis), Gymnopilus (Spectabilis, Others), Panaeolus), By Form (Fresh/Whole, Dried, Processed), By Application (Depression Relief, Anxiety Relief, De-addiction, Recreational, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F
... Recreational, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F In 2022, the United States Skin Cancer Therapeutics Market reached a valuation of USD 2.85 billion, and it is poised to experience robust growth in ... Read More
-
Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and Region (Asia Pacific, Europe, North America, Middle East & Africa, and South America) - Global Forecast to 2028
... pharmaceutical grade lithium carbonate market is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028. Lithium carbonate is commonly used ... Read More
-
North America HIV Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 30.0 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028. HIV, which stands for human immunodeficiency virus, is a type of retrovirus which damages the immune system by ... Read More
-
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030
... characterized by the death of brain cells, eventually leading to memory loss, cognitive dysfunction and dementia. Accounting for 60-70% cases of dementia, Alzheimer’s disease is known to be the sixth leading cause of death in ... Read More
-
Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035 Distribution by [A] Scale of Operation (Preclinical / Clinical and Commercial) [B] Type of Synthesis Method Used [C] Company Size (Small, Mid-sized and Large), and [D] Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts
... Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts Over the years, the popularity of biologics has led to an evident shift in the focus of ... Read More
-
North America Neurotoxins Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)
... Others) The North America neurotoxins market is expected to grow from US$ 4,801.29 million in 2023 to US$ 8,416.95 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2023 to ... Read More
-
North America Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The North America organoids market is expected to grow from US$ 1,357.19 million ... Read More
-
United States Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 37.69 billion by 2028, at a CAGR of 3.70% during the forecast period (2023-2028). COVID-19 has carved an especially fatal route through the 1 in 10 diabetics in the United States, including ... Read More
-
Mexico Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.31 billion by 2028, growing at a CAGR of 3.30% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older ... Read More
-
Intractable Focal Epilepsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Elevating Neurological Care for Intractable Focal Epilepsy The global intractable focal epilepsy treatment market is gaining significant traction as a critical field within neurology, focusing on tackling persistent focal seizures that resist conventional medications. This ... Read More
-
Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) Tailored Hormone Therapies Gain Momentum The global compounded bioidentical hormone therapy market is rapidly advancing, offering tailored hormone treatments with a multitude of applications. These therapies, utilizing bioidentical hormones, are anticipated to bring forth ... Read More
-
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition), 2021-2030: Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, and specific BET and DUB inhibitors and other inhibitors), Therapeutic Area (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)
... (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest ... Read More
-
US Urinary Tract Infection Therapeutics outlook to 2028
... a huge problem in the US. US typically see more than 8 million cases of UTIs every year. According to Ken Research, the US Urinary Tract Infection (UTI) Therapeutics market is anticipated to grow at ... Read More
-
United States Pain Management Therapeutics Market, Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Research. Physical and mental pain has a significant influence on life. It can hinder our daily activities, limit our mobility, and dampen our spirits. Advancements in medical technology and growing awareness have opened up new ... Read More
-
Sinusitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... a condition characterized by inflammation or swelling of the sinuses, has become a notable healthcare challenge, causing discomfort and decreased quality of life for patients. The condition, which often presents symptoms such as nasal congestion, ... Read More
-
Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Afric
... The global drug discovery informatics market is experiencing robust growth due to increased investments in novel research and development initiatives by pharmaceutical companies. A significant portion of time and financial resources is dedicated to drug ... Read More
-
Toxoplasmosis Treatment Market by Type (Acquired Toxoplasmosis and Congenital Toxoplasmosis), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies and Online Providers) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... RoW)-Forecast up to 2027 Toxoplasmosis is an infection caused due to a common parasite, which is present in cat feces and in contaminated food. This parasite is referred as Toxoplasma gondii. The symptoms of toxoplasmosis ... Read More
-
Dystonia Drugs Market by Drug Type (Anticonvulsants drugs, Others, Dopaminergic agents and GABAergic agents), Route of Administration (Oral and Injectable), Distribution Channel (Hospital Pharmacies, Online Providers and Drug Stores and Retail Pharmacies) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... America, Europe, APAC and RoW) - Forecast up to 2027 Dystonia can be referred to a movement disorder featured by involuntary muscle contractions which cause slow repetitive movements or abnormal postures. These muscle contractions result ... Read More
-
Oral Proteins and Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032
... Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032 INTRODUCTION Since the approval of the ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
... Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035 Clinical trials form an integral ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
Research Assistance
